Table 2 Demographic and clinical characteristics for screened and enrolled participants
|  | Screened participants: (N = 617 unless noted otherwise) | Enrolled: Participants: (N = 42) |
|---|---|---|
From population experiencing health disparities*, n (%) | 385 (62%) | 28 (67%) |
Age, Mean (SD) | 53.4 (15.8) | 52.9 (14.2) |
Age categories, n (%) | ||
0 to 17 | 1 (0.2%) | 0 (0%) |
18 to 34 | 95 (15%) | 5 (12%) |
35 to 49 | 146 (24%) | 14 (33%) |
50 to 64 | 191 (31%) | 14 (33%) |
65 to 79 | 171 (28%) | 9 (21%) |
Sex at birth, n (%) | ||
Female | 414 (69%) | 25 (59.5%) |
Male | 181 (30%) | 17 (40.5%) |
Education, n (%) | N = 597 |  |
No high school diploma | 12 (2%) | 1 (2%) |
High school graduate or GED | 40 (6%) | 4 (10%) |
Some college, no degree | 117 (19%) | 6 (14%) |
Associate degree | 78 (13%) | 6 (14%) |
Bachelor’s degree | 173 (28%) | 15 (36%) |
Master’s degree | 127 (21%) | 10 (24%) |
Smoking History, n (%) | N = 90 |  |
Never | 51 (57%) | 25 (59.5%) |
Current | 8 (9%) | 4 (9.5%) |
Former | 31 (34%) | 13 (31%) |
Clinical Characteristics | N = 90 |  |
BRLP duration in weeks, median (IQR) | 104 (0 to 1,560) | 156 (52 to 312) |
STarTBack, n (%) | N = 90 |  |
Low risk | 27 (30%) | 11 (26%) |
Medium risk | 48 (53%) | 23 (55%) |
High risk | 15 (17%) | 8 (19%) |
Pain Detect Score | N = 90 |  |
 < 13 – Unlikely neuropathic | 46 (51%) | 17 (40%) |
13–18 – Unclear if neuropathic | 30 (33%) | 15 (36%) |
 > 18 – Likely neuropathic | 14 (16%) | 10 (24%) |
Perceived risk BRLP will remain persistent (0 to 10 with higher scores indicating larger risk), mean (SD) | 7.5 (2.2) | 7.5 (2.1) |
Quebec Task Force Classification, n (%) | N = 76 |  |
2—Pain above the knee | 26 (34%) | 13 (31%) |
3—Pain below the knee | 29 (38%) | 15 (36%) |
4—Pain with neurological signs | 14 (18%) | 14 (33%) |
No BRLP or unclear classification | 7 (9%) | 0 (0%) |